Association between peripheral blood T cell subsets and clinical disability in multiple sclerosis patients

• by Penju Liu, Wei Liu, Xiaoting Zhang, Peng Yuan

• July 20, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

Mechanisms of Epstein-Barr virus-associated autoimmunity: a comparative overview

• by Fathima Shabnam, Gulfaraz Khan

• July 21, 2026

Donor-specific pathological features associate with genetic background, lesion type distribution, and clinical heterogeneity in multiple sclerosis

• by Lukas Lütje, J. Q. Alida Chen, Jörg Hamann, Joost Smolders, Inge Huitinga, Aletta M. R. van den Bosch

• June 25, 2026